Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Amarin Prices Public Offering of American Depositary Shares
-
ELS Reports Fourth Quarter Results
-
Amarin Corp. (AMRN) Plans Public Offering of American Depositary Shares
-
Amarin Announces Proposed Public Offering of American Depositary Shares
-
Amarin Announces Proposed Public Offering of American Depositary Shares
-
ProPhotonix New High-Performance PROdigii
-
Strongbridge Biopharma (SBBP) Prices 5M Offering of Ordinary Shares at $6.75/Share
-
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Dec 31
-
ProLogis (PLD) PT Raised to $70 at Cantor Fitzgerald
-
Aerie Pharma (AERI) Prices $75M Common Share Offering
-
Aerie Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Strongbridge Biopharma (SBBP) Plans Offering of 5M Ordinary Shares
-
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares
-
Aerie Pharma (AERI) to Offer $75M in Common Stock
-
Aerie Pharmaceuticals Announces Public Offering of Common Stock
-
HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Amarin Corp. (AMRN): Stock Has Room To Run Ahead of Data - Cantor
-
Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $60.4 Million
-
TipRanks Identifies the Top 20 Analysts of 2017
-
Worldplay Inc. (WP) PT Raised to $89 at Cantor Fitzgerald
-
Valeant (VRX) Defended at Cantor Fitzgerald Amd Cosmo Competition Fears
-
HTG Molecular Diagnostics (HTGM) Prices 12M Share Common Offering at $2.90/Sh
-
HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock
-
Anthem (ANTM) PT Raised to $275 at Cantor Fitzgerald on Lower Tax Rate
-
Investors yawn at latest U.S. government shutdown squabble
-
Arrowhead Pharmaceuticals Corp (ARWR) Prices 10M Common Stock Offering at $5.25/Share
-
Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock
-
Arrowhead Pharmaceuticals Corp (ARWR) Proposed Underwritten Offering of Common Stock
-
Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock
-
Genocea Biosciences (GNCA) Prices $55M Concurrent Public Offerings
-
Genocea Biosciences, Inc. Announces Pricing of $55 Million Concurrent Public Offerings
-
PlacementTracker Publishes 2017 PIPE and Private Placement Markets League Tables
-
Strongbridge Biopharma (SBBP) Buys U.S. and Canadian Rights to MACRILEN from Aeterna Zentaris (AEZS)
-
Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris
-
UPDATE: Cantor Fitzgerald Upgrades Luxoft Holding (LXFT) to Overweight Citing Improving Risk/Reward Profile
-
HTG Molecular Diagnostics (HTGM) Plans 10M Share Public Offering of Common Stock
-
Genocea Biosciences (GNCA) Announces Public Offerings of Common Stock, Class A Warrants, Series A Convertible Preferred Stock and Class A Warrants
-
HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
-
Genocea Biosciences, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Class A Warrants and Series A Convertible Preferred Stock and Class A Warrants
-
UnitedHealth Group (UNH) PT Raised to $280 at Cantor Fitzgerald
-
Infosys Technologies (INFy) PT Raised to $16 at Cantor Fitzgerald
-
ProPhotonix to Exhibit at Photonics West 2018
-
Evolent Health (EVH) PT Lowered to $28 at Cantor Fitzgerald, Says Shares Remain Compelling
-
Orchid Island Capital Announces January 2018 Monthly Dividend and December 31, 2017 RMBS Portfolio Characteristics
-
Veteran Investors and Operating Executives Launch Hunter Street Partners
-
Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit
-
Cantor Fitzgerald Remains Bullish on Perrigo (PRGO) Following CEO Appointment
-
Cantor Fitzgerald Reiterates Overweight on Aclaris Therapeutics (ACRS)
-
Evolus, Inc. Files Registration Statement for Proposed Initial Public Offering

